Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David W Hein

Showing results (41-50 of 171) with videos related to

Pageof 18
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|May 1, 2010
Codominant expression of N-acetylation and O-acetylation activities catalyzed by N-acetyltransferase 2 in human hepatocytesMark A Doll, Yu Zang, Timothy Moeller, et al.
Frontiers in Pharmacology|February 14, 2022
Arylamine <i>N</i>-Acetyltransferase 1 Activity is Regulated by the Protein Acetylation StatusRaúl A Salazar-González, Mark A Doll, David W Hein
Scientific Reports|May 7, 2020
Human arylamine N-acetyltransferase 2 genotype-dependent protein expression in cryopreserved human hepatocytesRaúl A Salazar-González, Mark A Doll, David W Hein
Pharmacogenomics|April 23, 2004
Chemopreventive drug treatment in subjects with genetic predisposition to cancer: prescriber liability and healthcare disparitiesLarry I Palmer, Robert C G Martin, David W Hein
Pharmacogenetics|March 6, 2003
Prostate expression of N-acetyltransferase 1 (NAT1) and 2 (NAT2) in rapid and slow acetylator congenic Syrian hamsterDavid W Hein, Mark A Doll, Gong H Xiao, et al.
Current Drug Metabolism|August 6, 2008
Structure/function evaluations of single nucleotide polymorphisms in human N-acetyltransferase 2Jason M Walraven, Yu Zang, John O Trent, et al.
Experimental Biology and Medicine (Maywood, N.J.)|December 25, 2007
Chemoprevention of arylamine-induced colorectal aberrant cryptsYi Feng, Jason R Neale, Mark A Doll, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 19, 2008
Systemic functional expression of N-acetyltransferase polymorphism in the F344 Nat2 congenic ratDavid W Hein, Jean Bendaly, Jason R Neale, et al.
AIMS Medical Science|December 5, 2015
Evaluation of Oxidative Stress Response Related Genetic Variants, Pro-oxidants, Antioxidants and Prostate CancerNicole Lavender, David W Hein, Guy Brock, et al.
Molecular Carcinogenesis|February 17, 2006
Tissue distribution of N-acetyltransferase 1 and 2 catalyzing the N-acetylation of 4-aminobiphenyl and O-acetylation of N-hydroxy-4-aminobiphenyl in the congenic rapid and slow acetylator Syrian hamsterDavid W Hein, Mark A Doll, Donald E Nerland, et al.
Pageof 18

Showing results (41-50 of 171) with videos related to

Sort By:
Pageof 18
The Journal of Pharmacology and Experimental Therapeutics|May 1, 2010
Codominant expression of N-acetylation and O-acetylation activities catalyzed by N-acetyltransferase 2 in human hepatocytesMark A Doll, Yu Zang, Timothy Moeller, et al.
Frontiers in Pharmacology|February 14, 2022
Arylamine <i>N</i>-Acetyltransferase 1 Activity is Regulated by the Protein Acetylation StatusRaúl A Salazar-González, Mark A Doll, David W Hein
Scientific Reports|May 7, 2020
Human arylamine N-acetyltransferase 2 genotype-dependent protein expression in cryopreserved human hepatocytesRaúl A Salazar-González, Mark A Doll, David W Hein
Pharmacogenomics|April 23, 2004
Chemopreventive drug treatment in subjects with genetic predisposition to cancer: prescriber liability and healthcare disparitiesLarry I Palmer, Robert C G Martin, David W Hein
Pharmacogenetics|March 6, 2003
Prostate expression of N-acetyltransferase 1 (NAT1) and 2 (NAT2) in rapid and slow acetylator congenic Syrian hamsterDavid W Hein, Mark A Doll, Gong H Xiao, et al.
Current Drug Metabolism|August 6, 2008
Structure/function evaluations of single nucleotide polymorphisms in human N-acetyltransferase 2Jason M Walraven, Yu Zang, John O Trent, et al.
Experimental Biology and Medicine (Maywood, N.J.)|December 25, 2007
Chemoprevention of arylamine-induced colorectal aberrant cryptsYi Feng, Jason R Neale, Mark A Doll, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 19, 2008
Systemic functional expression of N-acetyltransferase polymorphism in the F344 Nat2 congenic ratDavid W Hein, Jean Bendaly, Jason R Neale, et al.
AIMS Medical Science|December 5, 2015
Evaluation of Oxidative Stress Response Related Genetic Variants, Pro-oxidants, Antioxidants and Prostate CancerNicole Lavender, David W Hein, Guy Brock, et al.
Molecular Carcinogenesis|February 17, 2006
Tissue distribution of N-acetyltransferase 1 and 2 catalyzing the N-acetylation of 4-aminobiphenyl and O-acetylation of N-hydroxy-4-aminobiphenyl in the congenic rapid and slow acetylator Syrian hamsterDavid W Hein, Mark A Doll, Donald E Nerland, et al.
Pageof 18